NASHP Receives New Three-Year Serious Illness Grant from The John A. Hartford Foundation
September 29, 2022
The National Academy for State Health Policy is proud to announce the receipt of a new three-year grant beginning fall 2022 from The John A. Hartford Foundation, to expand and further build upon NASHP’s body of work in state serious illness policy.
NASHP will support multiple state teams through convening a multi-year Serious Illness Policy Institute learning collaborative; engage new state leaders on serious illness care by leveraging NASHP related activities and products; and support development of a 50-state Medicaid palliative care benefit cost calculator and tables using state-specific data.
Palliative care, which is specialized care that helps provide individuals relief from the symptoms and stressors of a serious illness, can help support person- centered goals and potentially lower costs through avoiding delivery of unwanted or unnecessary care. States have an opportunity to develop palliative care supports for beneficiaries with high need through developing policy to support individuals with serious illness within Medicaid.
To learn more:
- Check out NASHP’S work to date on palliative care, supported by The John A. Hartford Foundation.
- Sign up for NASHP’S palliative care newsletter



For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































